FLT3 Inhibitors in Mutant FLT3 AML

被引：0
|
作者：
Stone, Richard M. [1 ]
Garcia, Jacqueline [1 ]
机构：
[1] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave,D2053, Boston, MA 02215 USA
来源：
ANNALS OF HEMATOLOGY | 2017年 / 96卷
关键词：
ACUTE MYELOID-LEUKEMIA; NORMAL CYTOGENETICS; CONTROLLED-TRIAL; SORAFENIB; YOUNGER; PLACEBO;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S36 / S37
页数：2
相关论文
共 50 条
  • [31] Combinatorial treatment with menin and FLT3 inhibitors induces complete remission in AML models with activating FLT3 mutations
    Miao, Hongzhi
    Kim, EunGi
    Chen, Dong
    Purohit, Trupta
    Kempinska, Katarzyna
    Ropa, James
    Klossowski, Szymon
    Trotman, Winifred
    Danet-Desnoyers, Gwenn
    Cierpicki, Tomasz
    Grembecka, Jolanta
    BLOOD, 2020, 136 (25) : 2958 - +
  • [32] Gilteritinib Remains Clinically Active in Relapsed/Refractory FLT3 Mutated AML Previously Treated with FLT3 inhibitors
    Numan, Yazan
    Rahman, Zaid Abdel
    Grenet, Justin
    Boisclair, Stephanie
    Bewersdorf, Jan Philipp
    Barth, Dylan
    Zeidan, Amer M.
    Yilmaz, Musa
    Dinner, Shira
    Deutsch, Yehuda E.
    Frankfurt, Olga
    Litzow, Mark
    Al-Kali, Aref
    Foran, James M.
    Sproat, Lisa Z.
    Jovanovic, Borko
    Daver, Naval
    Perl, Alexander E.
    Altman, Jessica K.
    BLOOD, 2020, 136
  • [33] Novel Small Molecule FLT3 Inhibitors for the Treatment of FLT3-ITD AML
    Melgar, Katelyn
    Walker, MacKenzie
    Jiang, Jian-kang
    Wilson, Kelli
    Mulloy, James C.
    Thomas, Craig J.
    Starczynowski, Daniel T.
    BLOOD, 2015, 126 (23)
  • [34] FLT3 Inhibitor Treatment Increases FLT3 Expression That Exposes FLT3-ITD+ AML Blasts to Elimination By FLT3 CAR-T Cells
    Jetani, Hardikkumar
    Garcia-Cadenas, Irene
    Nerreter, Thomas
    Goetz, Ralph
    Sierra, Jorge
    Bonig, Halvard
    Sauer, Markus
    Einsele, Hermann
    Hudecek, Michael
    BLOOD, 2018, 132
  • [35] Glucocorticoids act synergistically with FLT3 inhibitors to enhance cell death in FLT3 mutant acute myeloid leukemia
    Gebru, Melat Tsegaye
    Wang, Hong-Gang
    Xavier, Jennifer
    CANCER RESEARCH, 2020, 80 (16)
  • [36] Is there evidence for the use of FLT3 inhibitors as maintenance therapy in AML?
    Levis, Mark
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2021, 34 (01)
  • [37] Characterization of dual resistant AML cells to FLT3 inhibitors
    Katayama, Kazuhiro
    CANCER SCIENCE, 2023, 114 : 1482 - 1482
  • [38] Further activation of FLT3 mutants by FLT3 ligand
    R Zheng
    E Bailey
    B Nguyen
    X Yang
    O Piloto
    M Levis
    D Small
    Oncogene, 2011, 30 : 4004 - 4014
  • [39] Further activation of FLT3 mutants by FLT3 ligand
    Zheng, R.
    Bailey, E.
    Nguyen, B.
    Yang, X.
    Piloto, O.
    Levis, M.
    Small, D.
    ONCOGENE, 2011, 30 (38) : 4004 - 4014
  • [40] Inhibition of FLT3 Expression by Green Tea Catechins in FLT3 Mutated-AML Cells
    Bui Thi Kim Ly
    Hoang Thanh Chi
    Yamagishi, Makoto
    Kano, Yasuhiko
    Hara, Yukihiko
    Nakano, Kazumi
    Sato, Yuko
    Watanabe, Toshiki
    PLOS ONE, 2013, 8 (06):
12345